Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06400355

Effect of Mannitol on Recovery Pattern After Orthognathic Surgery

Effect of Mannitol on Recovery Pattern After Orthognathic Surgery, a Prospective Randomized Double Blind Controlled Study.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
National Cancer Institute, Egypt · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to test, whether mannitol infusion in different doses will affect recovery pattern? the investigators hypothesized that infusion of mannitol in doses of 0.5 gm/kg before recovery from anesthesia after orthognathic surgery shortens patients' recovery time, and improves recovery quality, as well as postoperative cognitive function better.

Detailed description

The aim of this study is to test, whether mannitol infusion in different doses will affect recovery pattern? the investigators hypothesized that infusion of mannitol in doses of 0.5 gm/kg before recovery from anesthesia after orthognathic surgery shortens patients' recovery time, and improves recovery quality, as well as postoperative cognitive function better Methodology This prospective randomized double blinded study will be applied on patients scheduled for orthognathic surgeries as Temporo-mandibular joint procedures, Le Forte Ι 0r II osteotomy, bimax or maxillectomy after ethical committee approval. The selected patients were randomly allocated into two groups each containing 30 patients: * Group M: in which mannitol will be given in doses of 0.5 gm/kg 30 minutes before the end of the surgery * Group C: similar volume of the infused mannitol but of lactated Ringer will be given 30 minutes before the end of the surgery Anaesthetic technique: For all Patients, atropine sulphate 0.015 mg/kg intramuscular (IM) as anti-sialgogue together with dexamethasone 8 mg. Hydrocortisone 100 mg and ranitidine 50 mg, will be given IV as pre-medications 15-30 minutes before induction of anaesthesia patient will be transferred to the operating theatre where ASA-basic monitors will be applied to the patient (pulse-oxymitery, non-invasive blood pressure, ECG 3-Leads and capnography). Induction of anesthesia: Regular IV induction will be applied for patients with normal mouth opening where difficult intubation is not suspected: fentanyl 2 μg/kg IV, propofol 1 mg/kg IV, atracurium 0.5 mg/kg IV then nasotracheal intubation with armored tube of appropriate size. Patients with difficult mouth opening will undergo awake fiberoptic intubation. Anesthesia will be maintained by 100% O2 + 1-1.5 MAC isoflurane Thirty minutes before the end of surgery patients will receive an IV solution which is either mannitol 0.5 gm/kg or lactated Ringer.

Conditions

Interventions

TypeNameDescription
DRUGMannitolin which mannitol will be given in doses of 0.5 gm/kg 30 minutes before the end of the surgery
DRUGRinger's Lactatesimilar volume of the infused mannitol but of lactated Ringer will be given 30 minutes before the end of the surgery.

Timeline

Start date
2024-03-01
Primary completion
2024-06-01
Completion
2024-08-01
First posted
2024-05-06
Last updated
2024-07-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06400355. Inclusion in this directory is not an endorsement.